Home > PJ (current issue) > Agenda for 2007

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7449 p489-490
28 April 2007

This article
Reprint   Photocopy

PDF 40K, Acrobat Reader

Agenda for 2007

There will be a role for everyone in the new world unfolding for pharmacy

Writing in a personal capacity, the President of the Royal Pharmaceutical Society Hemant Patel outlines his vision for the profession's future

Agenda series


The pharmacy profession

Objectives

My vision

In conclusion

I have always tried to influence change by understanding the need for it and I have tried to get colleagues to respond positively by motivating and inspiring them, and making our goals clearer. With the discussions about the arrangements for a new regulatory body for pharmacy and a separate professional body ongoing, I remembered what John Smale, in the Harvard Business Review, wrote: “When you’re going to address a problem, get the people who have something to contribute in the way of creativity if not direct responsibility. Get them together. Turn them loose.”

The Royal Pharmaceutical Society believes that the formation of a new regulatory body and a professional leadership organisation will bring lasting benefits to professionals, to government and to the public. In fast-changing times the profession needs to be innovative, ambitious, strong and confident. So it needs robust and appropriate support structures at local and national level.

Working with others who have an interest in the success of pharmacy is the way to be sure a new professional body — a royal college — is a success. On Monday 30 April, the Society is starting the process of engaging in discussion with the rest of the profession and other pharmacy organisations. The Society believes, but does not take for granted, that it is well placed, working in partnership with the Pharmaceutical Society of Northern Ireland and others, to host a professional body. The Society wants to collaborate with other organisations in pharmacy. But this is not a new desire.

In my presidential policy statement of 2005 I said: “There is a need to transform the profession by co-creating a compelling vision for the future that respects our history and our increasing diversity (of membership and work). We can do better: I believe that change must be managed with a clear aim to bequeath to the next generation of pharmacists a profession which is in a better state than we inherited. We must renew our resolve to modernise the culture, education and practice of pharmacy, but set within a new context of facilitated and purposeful change management at individual and collective levels.”

In 2006 I said: “In the recent years debates have been about retaining the profession’s unique values, protecting our assets and our sense of identity. Now, the Council has to work with the branches to create a culture of increased innovation, commitment, performance measurement and good patient outcomes whilst at the same time adding meaning to people’s lives by creating an environment where pharmacists can practise and be fulfilled by their work. The Pharmacy 2020 project will do just that.”

Although I had radical change in mind nothing adequately prepared me for the scale of change unveiled in the Government White Paper “Trust, assurance and safety — the regulation of health professionals in the 21st century” published on 21 February. Coming some three years after the Government granted a new Royal Charter to the Society and following a taxing, hectic period to develop the Section 60 Order, I am impressed with the work rate, intellectual capital and sheer tenacity of the staff and the Council. They have clearly accepted the public policy need to separate the functions of the Society to reflect the Government’s thinking. So has the profession. This presents the Society with a challenge and an opportunity to start to develop a new focus for a professional body for pharmacists (and others, if the members agree).

Pharmacy 2020, like Pharmacy in a New Age, is the Society’s project to plan the profession’s future. By the time the White Paper was published the Society had already been working on it for over a year, but there is now a greater urgency and a greater commitment of time and resources required. An external review of the Society’s communications has already been commissioned. Its “Scoping the profession” project aimed to discover what support groups and organisations exist in pharmacy and what support they are providing to those working in pharmacy. The Society has carried out a consultation on values and ethics followed by the development of a new values-based code of ethics. It has also carried out a consultation on education that will influence future education and training. Crucially all this work has had valuable input from members of the Society.

In terms of planning the future the Society has a good track record but what it perhaps needs to improve on is its communications and dealing with here-and-now issues affecting its members.

The pharmacy profession

Society is changing and the pharmacy profession has to reflect that to remain relevant. The profession is going through a rapid change. In addition to providing a supply function, it is being repositioned to provide a medicines- and patient-centred health service that includes public health and clinical services. In the wider health care world we face a plurality of health provision and the breaking down of traditional professional boundaries. Within the profession there are various specialists, including an increasing number of generalists who are developing specialisms along with opportunities to work outside dispensaries. These developments must influence future practice, education and regulatory strategies. So discussions about representation in a future democratic professional body need careful thought in order to make that body relevant to the future needs of pharmacists — and perhaps others. These new structures should have an explicit duty to recognise and support specialisms and diversity within the profession.

The Royal Pharmaceutical Society is facing a future with new demands and new pressures — and possibly new competitors. Change is not only coming more quickly but at a cost. In challenging times the Society and all parts of the profession have to work together to maintain continuity with the past. It also needs to evolve rapidly by being flexible and fleet of foot.

Objectives

The recent White Paper aims to ensure that regulatory bodies for health professionals are competent and seen to be independent of their professions. So a number of questions arise:

• What is the ultimate goal of the Government?

• What problem is it trying to solve?

• What difference might the formation of a new pharmacy regulator and a royal college make?

• Will their establishment lead to the creation of a valued, confident and creative profession?

• What else, other than robust structures, is needed to make a demonstrable difference to pharmacists and the public?

• What kind of leadership and followers are required to make a difference?

• How will the leadership role be organised?

In order to stimulate discussion I offer below some early personal thoughts, which I hope are helpful.

I believe that the ultimate goal of the Government is to protect patients and the public from any avoidable harm and to hold the health professions and health organisations to account. The pharmacy profession’s ultimate objective is no different and it is worth noting that motivating and rewarding the professions is a means to an end.

My vision

My ambition is to make the UK the safest place in the world to take medicines. The chief medical officer, the chief pharmacists for England and Scotland and others, including the chairmen of the Royal College of General Practitioners and the Healthcare Commission, have all shown an interest in, and support for, this ambition.

The vision is simple, but how will we, as an important and central part of a multidisciplinary team, achieve the vision? It has to be through the Society taking the lead and supporting its members and others.

I want an examination of all aspects of our work as pharmacists and to ensure that we are seen to be demonstrably contributing to the social good. This, as agreed by the Council recently, is about starting a critical examination of a drug’s journey from raw material to manufacture, from manufacture to supply, and from supply to administration. This examination must be carried out with a view to defining areas where pharmacists, working with others, can contribute to safety and efficacy. It should also involve an examination of prescribing and patient experiences, in order to improve safety. From this work we should be able to identify what support should be provided to pharmacists who are working collaboratively to ensure that no harm comes to patients.

What I am describing is the process of creating an empowered profession working within appropriate structures, increasing confidence and commitment by enhancing the value of the contribution of pharmacists in our communities, with the Society leading and supporting the process.

Empowerment is the new buzzword, taken to be the fix-all in the workplace. The Society is trying to meet the new challenges and is seeking to make improvements in the way it supports members. But this needs the involvement and commitment of members, too. Yet many members appear to resist and withdraw from these well intentioned and much needed efforts. To develop an empowered profession we need a new type of working relationship between the Society and its membership.

It takes more than a few meetings or a crash programme to develop pharmacist involvement and empowerment. It involves both pharmacists and the Society rethinking old ways and learning new ones. It may even demand a big shift in the way that the leadership operates.

Creating social capital and utilising it must be a new priority for the profession as it repositions itself in a more clinical and health-related role. Empowerment of pharmacists, too, is critical for the successful development of health care.

Empowered work relationships share power, responsibility, communication, expectations and rewards in ways that are different from relationships in a traditional hierarchical organisation. The current competitive environment and accompanying scarce resources in the profession require pharmacy leaders to behave differently in order to be effective and to help the profession to thrive.

We need to think about the three elements that make up what I call the empowered workplace:

• Attitudes, values, beliefs and behaviours

• Relationships, privileges and obligations

• Flatter (rather than hierarchical) structures, and learning

Each of these dimensions of the profession must adapt to create an empowered workplace, or the effort to liberate the creativity of pharmacists will be doomed to failure. The creation of a new professional body in itself will not lead to better creativity.

Core mind shifts in strategy and operations of the profession are required. The shift from getting the job done to attending to processes, taking responsibility for the development of the whole workplace or the profession, and solving problems using active learning, is at the core of the shift to empowerment of the Society and the individual pharmacist. We need to do three things: attend to processes, take responsibility, and seek and promote learning.

The Society as a professional body, needs, for example, to do the following:

• Support pharmacists much better in dealing with here-and-now issues as well as long-term planning and lobbying

• Create new opportunities for practice — prescribing and creation of other new clinical and public health roles provide new areas of opportunity

• Make practice easier by developing and disseminating support tools and guidance in a variety of areas

• Provide training and develop local and national leaders — the National Association of Women Pharmacists has already demonstrated how mentoring can work, so further development and rolling out of a mentoring programme is crucial to maintaining momentum and the broad appeal of this initiative

• Support local pharmacists through the branches and further develop the concept of pharmacy team working, thus creating training and networking opportunities for pharmacists and support staff

Where does clinical governance fit into all this? In addition to reaching its goal of dispensing safely and appropriately, a pharmacy team must look at how it gets there. It must be able to reach the goal again and do things better next time. It must develop self-awareness of how it does things, and this understanding must be shared within and outside the team.

In the empowered pharmacy team, everyone has the responsibility that was traditionally given to the pharmacist or leader. If anyone, including support staff, sees a problem or has an idea, he or she is responsible for bringing it to the team. The idea must be respected, and everyone should be engaged in looking for ways to grow and develop pharmacy practice. It is not enough for only the pharmacist or leader to do this.

In the past the Society has been reactive in some areas, either to Government plans or to the general environment. In an empowered organisation, people are willing to take action, to seek out and solve problems, to take risks, to speak out and to work together. They do not wait to be told and they are not paralysed by fear or caution.

There is much talk of leadership without anyone saying precisely what they mean by it. In my view leadership generally involves helping people do something differently from what would have done without your involvement — in short, a departure from the status quo. We at the Society want to offer the kind of leadership that those in the profession want to willingly follow. So at this time we need to discuss the relationship between the two and the following:

• Clarity of purpose of the exercise to form a professional body

• Morale — what will raise morale within the profession?

• Fairness — ensure all sectors and individuals feel that there is fairness in the system

• Recognition of diversity, specialisms, and individuals who excel

• Team work — organising local branches, national boards and work with the professional body

• Participation — if there is a duty to recognise excellence and achievement, should there be a complementary duty to participate in events and programmes?

• Communication — a new communications strategy at the Society is under preparation and this will, I hope, address the issues raised

In conclusion

The Royal Pharmaceutical Society has to deal with a vast range of issues and does not get it right every time. It needs to take action through better communication and strategies to ensure that the views of members and others are welcomed and considered appropriately. The Society needs to remember that there is no generic pharmacist and that he or she is a human being with responsibilities outside work and needs broader support as a member of a society.

And what about members’ responsibilities? Let me quote Walter Kiechel, former editorial director of Harvard Business School Publications: “Hereinafter, employees will assume full responsibility for their own careers — for keeping their qualifications up to date, for getting themselves moved to the next position at the right time, for salting away funds for retirement and, most daunting of all, for achieving job satisfaction. The company, while making no promises, will endeavour to provide a conducive environment, economic exigencies permitting.”

Back to Top


©The Pharmaceutical Journal